Münch Götz, Rosport Kai, Bültmann Andreas, Baumgartner Christine, Li Zhongmin, Laacke Lien, Ungerer Martin
ProCorde GmbH, Martinsried, Germany.
Circ Res. 2005 Oct 28;97(9):928-36. doi: 10.1161/01.RES.0000186685.46829.E5. Epub 2005 Sep 15.
A hyperadrenergic state is one of the key features of human and experimental heart failure. Decreased densities and activities of the presynaptic neuronal norepinephrine (NE) transporter uptake-1 occur both in patients and animal models. It is currently unclear to what extent the reduction of uptake-1 contributes to the deterioration of heart failure. Therefore, we investigated the effects of myocardial overexpression of uptake-1 in both nonfailing rabbit hearts and in an animal model of heart failure. Heart failure was induced in rabbits by rapid ventricular pacing. Adenoviral gene transfer was used to overexpress uptake-1 in the myocardium. Uptake-1 overexpression led to increased NE uptake capacity into the myocardium. In contrast, systemic plasma NE levels in uptake-1-overexpressing failing rabbits (uptake-1-CHF) did not differ from controls. Downregulation of SERCA-2 and beta-adrenergic receptors in the failing myocardium was significantly reversed after uptake-1 overexpression. Uptake-1 overexpression significantly improved left ventricular (LV) diameters (LV end-diastolic diameter: in GCP-overexpressing failing rabbits (GFP-CHF), 17.4+/-0.4 mm; in uptake-1-CHF rabbits, 15.6+/-0.6 mm) and systolic contractility (fractional shortening: GFP-CHF, 20.7+/-0.6%; uptake-1-CHF, 27.3+/-0.7%), as assessed by echocardiography at the end of the heart failure protocol. Intraventricular tip catheter measurements revealed enhanced contractile reserve (dP/dt max with isoproterenol 1.0 microg/kg: GFP-CHF, 6964+/-230 mm Hg/sec; uptake-1-CHF, 7660+/-315 mm Hg/sec) and LV relaxation (dP/dt min with isoproterenol 1.0 microg/kg: GFP-CHF: -3960+/-260 mm Hg/sec; uptake-1-CHF, -4910+/-490 mm Hg/sec). End-diastolic filling pressures (GFP-CHF, 8.5+/-1.2 mm Hg; uptake-1-CHF, 5.6+/-0.7 mm Hg) tended to be lower in uptake-1 overexpressing animals. In summary, local overexpression of uptake-1 in the myocardium results in marked structural and functional improvement of heart failure, thus underlining the importance of uptake-1 as a key protein in heart failure.
高肾上腺素能状态是人类和实验性心力衰竭的关键特征之一。在患者和动物模型中,突触前神经元去甲肾上腺素(NE)转运体摄取-1的密度和活性均降低。目前尚不清楚摄取-1的减少在多大程度上导致心力衰竭的恶化。因此,我们研究了在非衰竭兔心脏和心力衰竭动物模型中,心肌过表达摄取-1的影响。通过快速心室起搏诱导兔发生心力衰竭。采用腺病毒基因转移技术使摄取-1在心肌中过表达。摄取-1过表达导致心肌对NE的摄取能力增加。相比之下,摄取-1过表达的衰竭兔(摄取-1-CHF)的全身血浆NE水平与对照组无差异。摄取-1过表达后,衰竭心肌中肌浆网钙ATP酶-2(SERCA-2)和β-肾上腺素能受体的下调得到显著逆转。在心力衰竭实验结束时,通过超声心动图评估,摄取-1过表达显著改善了左心室(LV)直径(左心室舒张末期直径:在绿色荧光蛋白过表达的衰竭兔(GFP-CHF)中为17.4±0.4mm;在摄取-1-CHF兔中为15.6±0.6mm)和收缩期收缩力(缩短分数:GFP-CHF为20.7±0.6%;摄取-1-CHF为27.3±0.7%)。心室内尖端导管测量显示收缩储备增强(异丙肾上腺素1.0μg/kg时的dP/dt max:GFP-CHF为6964±230mmHg/秒;摄取-1-CHF为7660±315mmHg/秒)和左心室舒张(异丙肾上腺素1.0μg/kg时的dP/dt min:GFP-CHF为-3960±260mmHg/秒;摄取-1-CHF为-4910±490mmHg/秒)。摄取-1过表达动物的舒张末期充盈压(GFP-CHF为8.5±1.2mmHg;摄取-1-CHF为5.6±0.7mmHg)趋于更低。总之,心肌中摄取-1的局部过表达导致心力衰竭在结构和功能上得到显著改善,从而突出了摄取-1作为心力衰竭关键蛋白的重要性。